A review of BMP and Wnt signaling pathway in the pathogenesis of pulmonary arterial hypertension
Authors:
- 25 November 2021
- journal article
- review article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 44 (2) , 175-180
Abstract
Pulmonary arterial hypertension (PAH) is a chronic disease characterized by a progressive elevation in mean pulmonary arterial pressure. This occurs due to abnormal remodeling of small peripheral lung vasculature resulting in progressive occlusion of the artery lumen that eventually causes right heart failure and death. Current therapeutic options for PAH are limited and focused mainly on reversal of pulmonary vasoconstriction and proliferation of vascular cells. Although these treatments can relieve disease symptoms, PAH remains a progressive lethal disease. Bone morphogenetic proteins (BMPs) and their receptors were required for PAH-induced right ventricular hypertrophy. Emerging data suggest that restoration of BMP type II receptor (BMPR2) signaling in PAH is a promising alternative that could prevent and reverse pulmonary vascular remodeling. BMPR2 mutations have been identified in >70% of familial and roughly 15% of sporadic PAH cases. Wingless (Wnt) are a family of secreted glycoproteins with varying expression patterns and a range of functions, Wnt signaling pathway is divided into canonical signaling pathway and non-canonical signaling pathway. A recent study reports that interaction between BMP and Wnt closely associated with lung development, those cascade coordination regulation stem cell fate which determine lung branching morphogenes. The promoting effect of BMPR2 on proliferation, survival, and motility of endothelial cells was through recruiting Wnts signaling pathway, the interaction between BMP and Wnt closely associated with lung development. Therefore, in this review, we outline the latest advances of BMP and Wnt signaling pathway in the pathogenesis of PAH and disease progression.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2020MH001)
- Science and Technology Development Project of Jinan Medical and Health (202019126)
- Science and Technology Development Project of Shandong Province (2019GSF107093)
This publication has 55 references indexed in Scilit:
- Molecular pathogenesis of pulmonary arterial hypertensionJournal of Clinical Investigation, 2012
- Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary HypertensionCirculation, 2012
- Disruption of PPARγ/β-catenin–mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survivalJournal of Clinical Investigation, 2011
- ID family protein expression and regulation in hypoxic pulmonary hypertensionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- WNT5A Is a Regulator of Fibroblast Proliferation and Resistance to ApoptosisAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt–β-catenin and Wnt–RhoA–Rac1 pathwaysJournal of Cell Biology, 2009
- Modular control of endothelial sheet migrationGenes & Development, 2008
- Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Bone Morphogenetic Protein (BMP) Type II Receptor Is Required for BMP-mediated Growth Arrest and Differentiation in Pulmonary Artery Smooth Muscle CellsJournal of Biological Chemistry, 2008
- TGF-β-induced EMT: mechanisms and implications for fibrotic lung diseaseAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007